All blog items

A recent shift for NIH-funded T32 graduate training programs, especially those supported by the National Institute for General Medical Sciences (NIGMS), has been to emphasize trainee focused educational objectives. PhD students in T32-funded programs are expected to attain technical (research) operational (skills), and professional (career) competencies that prepare them for entering diverse careers.

A STAT News investigation into Orthopaedic Surgery, deeming it "the whitest specialty."

The Duke University School of Medicine Office of Biomedical and Graduate Education (OBGE) and Precision Genomics Collaboratory awarded 10 pilot grants of $2,000 each to SOM Biomedical PhD students.

The work of research team that includes Dr. David Montefiori of the Duke Human Vaccine Institute is highlighted in the NIH Director's Blog.

Think of the inner circuitry of the brain as a traffic network. When nerve cells release a signal, the information speeds along various routes to its destination: another nerve cell elsewhere in the brain. Neurobiologist Josh Huang, PhD, is especially interested in a particular type of inhibitory nerve cells called chandelier cells.

Zhao Zhang, PhD — ZZ to just about everyone — is a bit of a scientific outlier. While most of his bioscience colleagues around the world are studying the 23,000 protein-coding genes that make us human, the assistant professor of pharmacology and cancer biology is looking at the other part of the genome and asking what it does.

When William J. Fulkerson, MD, MBA, steps down from his illustrious tenure as executive vice president of Duke University Health System (DUHS) at the end of this year, he will be celebrated as one of the most influential and successful figures in Duke Health’s 90-year history.

A new test can quickly test the ability of antibodies to neutralize spike proteins from different variants of COVID-19 simultaneously. The D4 assay shown here is the Teflon-like technology that makes the test possible.

Emily Wang, MD’03, initially intended to study HIV research and treatment, but midway through medical school she became interested in the issues facing inmate populations. Now a professor in the Yale School of Medicine, she explores the health effects that mass incarceration has on populations both inside and outside of prison — a subject that the COVID-19 pandemic has thrown into sharp relief.

With $21 million in new funding from the NIAID, the network now includes eight centers in North America and will study adolescent lung transplant recipients as well as adult.